Almost one thousand companies and organizations from many countries around the world participated in the exhibition.
Upper Biotech’s new offerings – OTTOMAN and MAYA as well as Serum Amyloid A (SAA) – were the subject of much interest from end-users and distributors alike.
Over the three days, Upper Biotech held meetings with over ten western companies to discuss distribution, technical collaboration and investment opportunities. The meetings were very positive and some resulted in agreements being signed at the conference.
Through attending seminars and interfacing with other IVD companies, Upper Biotech gained a valuable insight into trends in the IVD market that will make new demands on our R & D efforts.
For Upper Biotech, attending the Annual Meeting of AACC each year presents us with a new beginning and new challenges.
We look forward to welcoming you to our booth at the 2016 AACC meeting in Philadelphia (July 31 – August 4, 2016).